Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benza

Showing results (271-280 of 361) with videos related to

Pageof 37
Sort By:
Journal of the American College of Cardiology|September 13, 2002
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic studyMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
JAMA|March 28, 2002
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trialMichael S Cuffe, Robert M Califf, Kirkwood F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Echo Research and Practice|June 7, 2026
Reporting changes in right ventricular systolic pressure: insights from Classification and Regression Tree (CART) analysisShadi P Bagherzadeh, Kartik S Malunjkar, Neha M Mantri, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Journal of Clinical Pharmacology|December 21, 2007
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusionC Shane McSwain, Ray Benza, Shelley Shapiro, et al.
Biochemistry|May 14, 1996
Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysisX N Li, J C Koons, R L Benza, et al.
International Journal of Cardiology|March 10, 2019
Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertensionMuhammad Shahzeb Khan, Emaan Amin, Muhammad Mustafa Memon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 14, 2012
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung TransplantationJames C Fang, Teresa DeMarco, Michael M Givertz, et al.
Pageof 37

Showing results (271-280 of 361) with videos related to

Sort By:
Pageof 37
Journal of the American College of Cardiology|September 13, 2002
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic studyMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
JAMA|March 28, 2002
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trialMichael S Cuffe, Robert M Califf, Kirkwood F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Echo Research and Practice|June 7, 2026
Reporting changes in right ventricular systolic pressure: insights from Classification and Regression Tree (CART) analysisShadi P Bagherzadeh, Kartik S Malunjkar, Neha M Mantri, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Journal of Clinical Pharmacology|December 21, 2007
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusionC Shane McSwain, Ray Benza, Shelley Shapiro, et al.
Biochemistry|May 14, 1996
Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysisX N Li, J C Koons, R L Benza, et al.
International Journal of Cardiology|March 10, 2019
Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertensionMuhammad Shahzeb Khan, Emaan Amin, Muhammad Mustafa Memon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 14, 2012
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung TransplantationJames C Fang, Teresa DeMarco, Michael M Givertz, et al.
Pageof 37